Abstract
Objective
Prompted by an alarmingly low screening rate for metabolic bone disease of prematurity (MBDP), we aimed to increase MBDP screening with serum calcium, phosphorous, and alkaline phosphatase at four to six weeks of life in infants born at <1500 g and <32 gestational weeks from a baseline of 27.37% to 90% within one year.
Study design
We used the Institute for Healthcare Improvement’s Model for Improvement as a framework. A key driver diagram informed the interventions which were carried out through four Plan-Do-Study-Act cycles.
Results
There were 129 and 130 neonates in the pre-intervention baseline group and post-intervention MBDP bundle group, respectively. MBDP bundled primary screening rates increased from 27.37% to 95.56% (p < 0.001). Furthermore, 20% of infants had an individualized change in their enteral mineral supplementation after the initiative.
Conclusions
An interdisciplinary team-based quality improvement approach was effective in altering clinical practice to improve screening and subsequent treatment for MBDP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Backström MC, Kuusela AL, Mäki R. Metabolic bone disease of prematurity. Ann Med. 1996;28:275–82.
Rustico SE, Calabria AC, Garber SJ. Metabolic bone disease of prematurity. J Clin Transl Endocrinol. 2014;1:85–91.
Kovacs CS. Calcium, phosphorus, and bone metabolism in the fetus and newborn. Early Hum Dev. 2015;91:623–8.
Chacham S, Pasi R, Chegondi M, Ahmad N, Mohanty SB. Metabolic bone disease in premature neonates: an unmet challenge. J Clin Res Pediatr Endocrinol. 2020;12:332–9.
Avila-Alvarez A, Urisarri A, Fuentes-Carballal J, Mandiá N, Sucasas-Alonso A, Couce ML. Metabolic bone disease of prematurity: risk factors and associated short-term outcomes. Nutrients. 2020;12:3786.
Faienza MF, D’Amato E, Natale MP, Grano M, Chiarito M, Brunetti G, et al. Metabolic bone disease of prematurity: diagnosis and management. Front Pediatr. 2019;7:143.
Montaner Ramón A. Risk factors of bone mineral metabolic disorders. Semin Fetal Neonatal Med. 2020;25:101068.
Vignochi CM, Silveira RC, Miura E, Canani LH, Procianoy RS. Physical therapy reduces bone resorption and increases bone formation in preterm infants. Am J Perinatol. 2012;29:573–8.
Lucas A, Brooke OG, Baker BA, Bishop N, Morley R. High alkaline phosphatase activity and growth in preterm neonates. Arch Dis Child. 1989;64:902–9.
Fewtrell MS, Cole TJ, Bishop NJ, Lucas A. Neonatal factors predicting childhood height in preterm infants: evidence for a persisting effect of early metabolic bone disease? J Pediatr. 2000;137:668–73.
Rigo J, Nyamugabo K, Picaud JC, Gerard P, Pieltain C, De Curtis M. Reference values of body composition obtained by dual energy X-ray absorptiometry in preterm and term neonates. J Pediatr Gastroenterol Nutr. 1998;27:184–90.
Backström MC, Kouri T, Kuusela AL, Sievänen H, Koivisto AM, Ikonen RS, et al. Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr. 2000;89:867–73.
Land C, Schoenau E. Fetal and postnatal bone development: reviewing the role of mechanical stimuli and nutrition. Best Pract Res Clin Endocrinol Metab. 2008;22:107–18.
Rayannavar A, Calabria AC. Screening for metabolic bone disease of prematurity. Semin Fetal Neonatal Med. 2020;25:101086.
Chinoy A, Mughal MZ, Padidela R. Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences. Arch Dis Child - Fetal Neonatal Ed. 2019;104:F560–6.
Harrison CM, Gibson AT. Osteopenia in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2013;98:F272–5.
Harrison C, Johnson K, McKechnie E. Osteopenia of prematurity: a national survey and review of practice. Acta Paediatr. 2008;97:407–13.
Kelly A, Kovatch KJ, Garber SJ. Metabolic bone disease screening practices among U.S. neonatologists. Clin Pediatr. 2014;53:1077–83.
Abrams SA, the CON, Bhatia JJS, Abrams SA, Corkins MR, de Ferranti SD, et al. Calcium and vitamin D requirements of enterally fed preterm infants. Pediatrics. 2013;131:e1676–e83.
Langley GJ Moen RD, Nolan KM, Nolan TW, Norman CL, Provost L. The improvement guide: a practical approach to enhancing organizational performance. 2 ed: Jossey Bass Wiley; 2009.
Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25:986–92.
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.
Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. an evidence-based approach. Am J Respir Crit Care Med. 2019;200:751–9.
Provost LP, Murray SK. The health care data guide : learning from data for improvement. 1st ed. San Francisco, CA: Jossey-Bass; 2011. xxviii, 445 p.
Sabroske EM, Payne DH, Stine CN, Kathen CM, Sollohub HM, Kohlleppel KL, et al. Effect on metabolic bone disease markers in the neonatal intensive care unit with implementation of a practice guideline. J Perinatol. 2020;40:1267–72.
Chin LK, Doan J, Teoh YS, Stewart A, Forrest P, Simm PJ. Outcomes of standardised approach to metabolic bone disease of prematurity. J Paediatr Child Health. 2018;54:665–70.
Krithika MV, Balakrishnan U, Amboiram P, Shaik MSJ, Chandrasekaran A, Ninan B. Early calcium and phosphorus supplementation in VLBW infants to reduce metabolic bone disease of prematurity: a quality improvement initiative. BMJ Open Qual. 2022;11:e001841.
Jeong E, Jung YH, Shin SH, Kim MJ, Bae HJ, Cho YS, et al. The successful accomplishment of nutritional and clinical outcomes via the implementation of a multidisciplinary nutrition support team in the neonatal intensive care unit. BMC Pediatr. 2016;16:113.
Lagerquist E, al-Haddad BJS, Irvine J, Muskthel L, Rios A, Upadhyay K. Feeding volume advancement in preterm neonates: a level 4 neonatal intensive care unit quality improvement initiative. Nutr Clin Pract. 2023;38:1175–80.
Olsen IE, Richardson DK, Schmid CH, Ausman LM, Dwyer JT. Dietitian involvement in the neonatal intensive care unit: more is better. J Am Diet Assoc. 2005;105:1224–30.
Rickard K, Gresham E. Nutritional considerations for the newborn requiring intensive care. J Am Diet Assoc. 1975;66:592–600.
Stark AR, Pursley DM, Papile L-A, Eichenwald EC, Hankins CT, Buck RK, et al. Standards for levels of neonatal care: II, III, and IV. Pediatrics. 2023;151:e2023061957.
Dye ME, Pugh C, Sala C, Scott TA, Wallace T, Grubb PH, et al. Developing a unit-based quality improvement program in a large neonatal ICU. Jt Comm J Qual Patient Saf. 2021;47:654–62.
Mills PD, Weeks WB. Characteristics of successful quality improvement teams: lessons from five collaborative projects in the VHA. Jt Comm J Qual Saf. 2004;30:152–62.
Olsson J, Elg M, Lindblad S. System characteristics of healthcare organizations conducting successful improvements. J Health Organ Manag. 2007;21:283–96.
Ozkaynak M, Unertl KM, Johnson SA, Brixey JJ, Haque SN. Clinical workflow analysis, process redesign, and quality improvement. In: Finnell JT, Dixon BE, editors. Clinical informatics study guide: text and review. Cham: Springer International Publishing; 2016. p. 135–61.
Unertl KM, Novak LL, Johnson KB, Lorenzi NM. Traversing the many paths of workflow research: developing a conceptual framework of workflow terminology through a systematic literature review. J Am Med Inform Assoc. 2010;17:265–73.
Rehman MU, Narchi H. Metabolic bone disease in the preterm infant: current state and future directions. World J Methodol. 2015;5:115–21.
Kaplan HC, Provost LP, Froehle CM, Margolis PA. The Model for Understanding Success in Quality (MUSIQ): building a theory of context in healthcare quality improvement. BMJ Qual Saf. 2012;21:13–20.
Acknowledgements
We would like to acknowledge the significant assistance of physicians, advanced practice providers, nurses, and dietitians in the successful execution and maintenance of this initiative. We would also like to thank Elisa Sarmiento for providing statistical support.
Funding
This project was funded, in part, with support from the Indiana Clinical and Translational Sciences Institute, in part by Grant Number UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Contributions
All authors were all involved int eh conceptualization of this study and in implementation of the quality improvement initiative. PC was responsible for collecting data through chart review. PC, KH, and BS were responsible for data analysis. PC drafted the initial manuscript. All authors were involved in reviewing and editing the manuscript. All authors agree to be accountable for all aspects of the work and final approval of the version to be published.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Creed, P.V., Huff, K.A., Beard, K. et al. Metabolic bone disease of prematurity screening and individualized enteral mineral supplementation in high-risk neonates: a quality improvement initiative. J Perinatol (2024). https://doi.org/10.1038/s41372-024-01892-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41372-024-01892-9